Send us a link
It started with a tweet, but now it's an international movement. Spurred by concerns about the impact President Donald Trump's administration might have on research, the March for Science is "a call to support and safeguard the scientific community."
In this approach, the goal of a scientist is transformed from convincing an editorial board through a vertical process to convincing peers through an horizontal one.
The establishment of university-affiliated incubators is often followed by a reduction in the quality of university innovations, according to a new study co-authored by a Baylor University entrepreneurship professor.
Virtualitics launches software that immerses viewers in complex models of data
A good book evokes a variety of emotions as you read. Turns out, though, that almost all novels and plays provide one of only six “emotional experiences” from beginning to end—a rags-to-riches exuberance, say, or a rise and fall of hope.
An expert group appointed by the government has proposed to change the procedures on how research funding from the Research Council of Norway is distributed and to cut the administrative budget of the research council by NOK80 million (US$9.6 million).
Any science enthusiast doing genetic engineering outside of a licensed facility might face a fine of €50,000 or up to three years in prison.
Now we know the identity of the chief executive of UK Research and Innovation, the science community will be anxiously watching his first steps.
The EU should listen to the innovators, knowledge creators and developers when it comes to data mining: the potential benefits are too great to be ignored, writes Helen Frew.
Authors want to know about citations, downloads, and impact metrics. This post reviews common metrics and explores the limitations inherent in each.
The growth of open access hasn't significantly changed the publishing landscape as regards impact factor.
Elsevier integrated Plum Analytics and Quertle to assist researchers in analyzing higher number of articles and identifying the correct one for their research.
Nobel-winning inventor of ways to modify genes
When politics meddles with science, it can lead to tragedy, as was the case with Stalin's favourite agricultural biologist Trofim Lysenko and his rival Nikolai Vavilov.
This episode we spoke to Max Hodak Founder and CEO of Transcriptic, a Menlo Park based biotech company offering a robotic solution to research in the life sciences.
Bubbling beakers, blazing Bunsen burners, boiling broths and a book.
An overview of the new rules to consider where scientific projects include the processing of personal data.
The Scholix initiative is a high level interoperability framework for exchanging information about the links between scholarly literature and data.
Each scientist and engineer chosen will receive an average of up to $300,000 per year for 5 years for life sciences research.
22 April demonstrations planned for more than 100 cities around the world
There are more academic publishers out there than ever before. In 2014 there was an estimated 28,100 active scientific journals, but while the large majority of these journals are highly respected, there has also been a sharp rise in the number of predatory journals.
Social media platforms such as Twitter can be effectively used for connecting with scientific communities across the globe, facilitating knowledge exchange.
Replacing the real world with a virtual one is a neat trick. Combining the two could be more useful.
This is one of our biggest failures as a scientific community — we haven’t done a good job of actually communicating with people about what we do.
In the wake of the Flint water crisis and with a new notably anti-science president, U.S. scientists are reevaluating how to navigate the tension between speaking out and a fear of losing research funding.
Two countries vie to invest more of their economy into research than anyone else.
And why should you care? There's a global trend of companies integrating hackathons into their overall innovation strategy.
Nearly 100 founders and leaders of biotech companies express their deep concern and opposition to the executive order signed by President Donald Trump on January 27, 2017.
A road map for the founding entrepreneur who seeks to retain the CEO position as a company gains market traction and begins a period of rapid growth.
